Nicole Germino

Stock Analyst at Truist Securities

(3.63)
# 282
Out of 5,441 analysts
31
Total ratings
Success rate
Average return
8 Stocks
Name Action PT Current % Upside Ratings Updated
INSM Insmed
Maintains: Strong Buy
126 139
112.87 23.15% 9 Aug 14, 2025
YMAB Y-mAbs Therapeutics
Maintains: Buy
18 14
8.52 64.32% 3 May 14, 2025
CATX Perspective Therapeu...
Maintains: Buy
10 8
3.72 115.05% 3 May 14, 2025
SGMO Sangamo Therapeutics
Maintains: Buy
7 5
n/a n/a 5 Jan 23, 2025
FUSN Fusion Pharmaceutica...
Downgrades: Hold
11 21
21.55 -2.55% 3 Mar 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
13 13
12.5 0% 3 Oct 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
132 24
23.54 1.95% 3 Oct 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Sep 3, 2021